Annexon Inc (ANNX)
4.61
+0.16
(+3.60%)
USD |
NASDAQ |
Apr 24, 10:19
Annexon Cash from Operations (TTM): -121.14M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -121.14M |
September 30, 2023 | -124.80M |
June 30, 2023 | -127.23M |
March 31, 2023 | -119.01M |
December 31, 2022 | -116.31M |
September 30, 2022 | -117.49M |
June 30, 2022 | -116.49M |
March 31, 2022 | -112.96M |
December 31, 2021 | -106.11M |
Date | Value |
---|---|
September 30, 2021 | -97.04M |
June 30, 2021 | -80.91M |
March 31, 2021 | -66.53M |
December 31, 2020 | -53.09M |
September 30, 2020 | -42.62M |
June 30, 2020 | -35.91M |
March 31, 2020 | -32.36M |
December 31, 2019 | -28.36M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-127.23M
Minimum
Jun 2023
-28.36M
Maximum
Dec 2019
-88.14M
Average
-106.11M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Trxade Health Inc | -2.074M |
P3 Health Partners Inc | -76.03M |
Arrowhead Pharmaceuticals Inc | -196.21M |
Insmed Inc | -536.25M |
Heron Therapeutics Inc | -58.79M |